Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Urologic Neoplasms × pembrolizumab × Clear all

Phase

Status

Recruiting 2 Unknown 1 Terminated 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 29 Melanoma 20 Neoplasms 11 Breast Neoplasms 10 Squamous Cell Carcinoma of Head and Neck 9 Lung Neoplasms 9 Triple Negative Breast Neoplasms 8 Stomach Neoplasms 8 Ovarian Neoplasms 8 Neoplasm Metastasis 8 Head and Neck Neoplasms 8 Pancreatic Neoplasms 7 Colorectal Neoplasms 7 Carcinoma, Renal Cell 7 Carcinoma, Hepatocellular 6 Carcinoma 5 Uterine Cervical Neoplasms 4 Prostatic Neoplasms 4 Hodgkin Disease 4 Esophageal Neoplasms 4 Lymphoma 3 Liver Neoplasms 3 Kidney Neoplasms 3 Glioblastoma 3 Esophageal Squamous Cell Carcinoma 3 Carcinoma, Transitional Cell 3 Neoplasms, Squamous Cell 2 Mesothelioma 2 Gastrointestinal Neoplasms 2 Fallopian Tube Neoplasms 2

Interventions

zidovudine 5'-monophosphate-mannose-albumin conjugate 1 tislelizumab 1 pembrolizumab 1 galactosamine-conjugated serum albumin-conjugated-(rhodamine X)20 1 atezolizumab 1 Water 1 Therapeutics 1 Surgical Procedures, Operative 1 Ringer's acetate 1 Preoperative Exercise 1 Nutritional Support 1 Immunoglobulins, Intravenous 1 Exercise 1 Ethanol 1 Dosage Forms 1 Biological Therapy 1 Albumins 1 Adiposity 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04931979 2023-03-01

Pembro-SRT

University Hospital Freiburg

Phase 2 Unknown

Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡